Toxicology reports are essential in Taiwan’s drug registration to assess a drug’s safety profile before clinical trials and market approval. These reports evaluate potential toxic effects, including acute and chronic toxicity, carcinogenicity, and reproductive toxicity. The TFDA uses this data to ensure that the drug poses minimal risks to public health.